Díaz-Castro, Alexander
January 2009
Revista Colombiana de Obstetricia y Ginecologia;2009, Vol. 60 Issue 1, p93
Academic Journal
Background: as systemic lupus erythematosus (SLE) is a common disease in young women and does not affect fertility cases may usually be found in which a woman can be both pregnant and suffer from this disease at the same time. Even though prognosis has improved, SLE should still be considered as a high risk disease and should be followed up by a multidisciplinary team enjoying excellent ongoing communication. This case presentation was aimed at reviewing maternal prognosis regarding base disease, gestation and the foetus. Case summary: a 35-year-old woman suffering form SLE and chronic arterial hypertension was being managed for cervical cancer (HG-ISL). During her treatment she became pregnant, thereby complicating the foetus' health and her own. Conclusions: interdisciplinary teams should be promoted in Colombia in hospitals so that particular management can be established for each patient presenting this type of disease as well as time limits on waiting. A social support network must be made available allowing the mother and newborn to feel welcome and be managed together, since they form a single unit differently to other cases involving patients suffering from cancer and lupus.


Related Articles

  • C1q complement component and -antibodies reflect SLE activity and kidney involvement. Horák, P.; Heřmanová, Z.; Zadražil, J.; Ciferská, H.; Ordeltová, M.; Kusá, L.; Žurek, M.; Tichý, T. // Clinical Rheumatology;Aug2006, Vol. 25 Issue 4, p532 

    The role of the complement system in the pathogenesis of systemic diseases is very ambivalent. In systemic lupus erythematosus (SLE), many abnormalities in the activation of the complement system have been reported. The most important antibodies formed against the complement system in SLE are...

  • Systemic lupus erythematosus presenting with eosinophilic enteritis: a case report.  // Journal of Medical Case Reports;2011, Vol. 5 Issue 1, p1 

    The article presents a case study of a 38-year-old woman who was admitted with a 5 month history of diarrhea and abdominal pain, and was later diagnosed with systemic lupus erythematosus (SLE). As reported, although initial medical examination revealed nothing abnormal apart from lymphopenia and...

  • Systemic Lupus Erythematosus (SLE). Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p624 

    A definition of the term "systemic lupus erythematosus" is presented. It refers to the chronic inflammatory autoimmune disease of unknown etiology. The disease is characterized by the involvement of multiple target organs such as the skin, lungs, kidneys and nervous system. The production of...

  • Membranous lupus nephritis. Austin, H. A.; Illei, G. G. // Lupus;2005, Vol. 14 Issue 1, p65 

    Membranous lupus nephritis (MLN) represents about 20% of clinically significant renal disease in lupus. Few studies have addressed directly the pathogenesis of MLN. Our assumptions about the underlying mechanisms are based on the combination of extrapolations from idiopathic membranous nephritis...

  • Two cases of systemic lupus erythematosus complicated by hydronephrosis and unique small structures observed in the glomerular basement membrane. Jinguji, Yoshimi; Nukui, Ikuo; Wakasugi, Masakiyo; Yamashita, Haruo // Clinical & Experimental Nephrology;Dec2008, Vol. 12 Issue 6, p467 

    We report two cases having a similar clinical profile of systemic lupus erythematosus (SLE) complicated by hydronephrosis that developed concurrently with a similar pathological recognition of numerous unique microspherical and microtubular structures in the glomerular basement membrane (GBM)....

  • A case of systemic lupus erythematosus showing invagination of the podocyte into the glomerular basement membrane: an electron microscopic observation of a repeated-renal biopsy. Sato, Masashi; Kogure, Teruko; Kanemitsu, Mineko // Clinical & Experimental Nephrology;Dec2008, Vol. 12 Issue 6, p455 

    A case of systemic lupus erythematosus (SLE) showing invagination of glomerular epithelial cells into the glomerular basement membrane (GBM) has been reported. The patient was a 30-year-old woman who was diagnosed with SLE at the age of 25 and had been medicated with corticosteroid. At the age...

  • Deconvolution of Blood Microarray Data Identifies Cellular Activation Patterns in Systemic Lupus Erythematosus. Abbas, Alexander R.; Wolslegel, Kristen; Seshasayee, Dhaya; Modrusan, Zora; Clark, Hilary F. // PLoS ONE;2009, Vol. 4 Issue 7, p1 

    Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease with a complex spectrum of cellular and molecular characteristics including several dramatic changes in the populations of peripheral leukocytes. These changes include general leukopenia, activation of B and T cells, and...

  • Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus. Holers, V. Michael // Journal of Clinical Investigation;Sep2004, Vol. 114 Issue 5, p616 

    Patients with systemic lupus erythematosus (SLE) often develop glomerulonephritis (i.e., inflammation in the glomeruli of the kidney), commonly referred to as lupus nephritis. Patients with lupus nephritis typically have autoantibodies to the complement classical pathway protein C1q. Whether...

  • Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB × NZWF[sub 1] mice. Hasegawa, K.; Hayashi, T. // Lupus;2003, Vol. 12 Issue 11, p838 

    The effect of synthetic CpG-oligodeoxynucleotides (CpG-ODN) on the development of lupus nephritis during preactive phase (within seven months of age) in autoimmune lupus NZB × NZWF[sub 1] (B/WF[sub 1]) mice was examined. Treatment of CpG-ODN was started at the age of 2.75 months and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics